Federal award
BAYER HEALTHCARE PHARMACEUTICALS INC
SPE2D024F0083
Contract
Obligated and Ceiling
- Obligated (net)
- $113,181.92
- Ceiling (potential value, not spending)
- $113,181.92
- Current value
- $113,181.92
- Gross positive obligations
- $121,591.76
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- BAYER HEALTHCARE PHARMACEUTICALS INC · V1EVGCK7XES8
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- BAYER AKTIENGESELLSCHAFT · NG4MKLABMVJ5
- Awarding agency
- Department of Defense · sub-agency 97AS · office SPE2D0
- Funding agency
- Department of Defense · sub-agency 97AS
- Product or service (PSC)
- 6505 · DRUGS AND BIOLOGICALS
- Industry (NAICS)
- 325411 · MEDICINAL AND BOTANICAL MANUFACTURING
- PIID
- SPE2D024F0083
- Parent vehicle (IDV PIID)
- SPE2D020D0004
- Award type code
- C
- Actions
- 2 · Feb 14, 2024 to Sep 6, 2024
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History2
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Sep 6, 2024 | FY2024 | P00001 | D | −$8,409.84 | — |
| Feb 14, 2024 | FY2024 | 0 | — | $121,591.76 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.